References
- Bandara G, Robbing P D, Georgescu H I, Mueller G M, Glorioso J C, Evans C H. Gene transfer to synoviocytes: prospects for gene treatment for arthritis. DNA Cell Biol 1992; 11: 227–31
- Evans C H, Robblns P D. Gene therapy for arthritis. Therapeutics: Methods and Applications of Direct Gene Transfer, J A Wolff. Birkhauser, Boston, MA 1994; 320–43
- Evans C H, Robblns P D. Prospects for treating arthritis by gene therapy. J Rheumatol 1994; 21: 779–82
- Evans C H, Robblns P D. Arthritis. Molecular and Cell Biology of Human Gene Therapeutics, G Dickson. Chapman and Hall, London 1995; 252–60
- Culver K, Cornetta K, Morgan R, et al. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 1991; 88: 3155–59
- Boggs S S, Patrene K D, Mueller G M, Evans C H, Doughty L A, Robbins P D. Prolonged systemic expression of human IL-1 receptor antagonist in sera of lethally irradiated mice reconstituted with hematopoietic stem cells transduced with a retrovirus containing the IL-1ra gene. Gene Therapy 1995, (in press)
- Raz E, Watanabe A, Balrd S M, et al. Systemic immunological effects of cytokine genes injected into muscle. Proc Natl Acad Sci USA 1993; 90: 4523–7
- Raper S E, Wilson J M. Cell transplantation in liver-directed gene therapy. Cell Transplant 1993; 2: 381–400
- Morgan J R, Barrandon Y, Green H, Mulligan R C. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 1987; 237: 1476–9
- St Louis D, Verma I M. An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci USA 1988; 85: 3150–4
- Rossler B J, Allen E D, Wilson J M, Hartman J W, Davidson B L. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 1993; 92: 1085–92
- Bandara G, Mueller G M, Galea-Lauri J, et al. Intraarticular expression of biologically active interleukin-1 receptor antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 1993; 90: 10764–8
- Hung G L, Galea-Lauri J, Mueller G M, et al. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Therapy 1994; 1: 64–9
- Nlta I, Galea-Lauri J, Georgescu H I, et al. Direct gene delivery to synovium. Trans Orthopaed Res Soc 1994; 19: 479
- Evans C H, Robbins P D. Possible orthopaedic applications of gene therapy. J Bone Joint Surg Am 1995; 77: 1103–15
- Otani K, Nita I, Macaulay W, et al. Suppression of antigen-induced arthritis in rabbit ex vivo gene therapy. Arthritis Rheum 1994; 37(Suppl)S295
- Lewthwaite J M, Blake S M, Hardlngham T E, Warden P J, Henderson B. Effect of recombinant human interleukin-1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J Rheumatol 1994; 21: 467–72
- Arend W P. Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167–227
- Evans C H, Robblns P D. The interleukin-1 receptor antagonist and its delivery by gene transfer. Receptor 1994; 4: 9–15